16 results
8-K
EX-1.1
GOSS
Gossamer Bio Inc
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
and regulations thereunder (the “FCPA”), or any other applicable anti-bribery or anti-corruption laws (the “Anti-Corruption Laws”) including, without limitation … , in contravention of the Anti-Corruption Laws and the Company and, to the knowledge of the Company, its affiliates have conducted their businesses in compliance
8-K
EX-1.2
GOSS
Gossamer Bio Inc
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
(the “FCPA”), or any other applicable anti-bribery or anti-corruption laws (the “Anti-Corruption Laws”) including, without limitation, making use … of the Anti-Corruption Laws and the Company and, to the knowledge of the Company, its affiliates have conducted their businesses in compliance with the Anti
8-K
EX-10.1
xtwqk1q34mx1o x6
3 May 19
Gossamer Bio Secures Debt Facility for Up to $150 Million
4:00pm
10-K
y4im6ombc48j6 xk
22 Mar 19
Annual report
4:45pm
424B4
6pj5 k50kwly
8 Feb 19
Prospectus supplement with pricing info
4:40pm
S-1/A
EX-1.1
rt97ip7 t1o5uz
23 Jan 19
IPO registration (amended)
4:39pm
S-1/A
qn8nmacd5khpvb41
23 Jan 19
IPO registration (amended)
4:39pm
S-1
nxrbyrkr aa
21 Dec 18
IPO registration
4:39pm
DRS/A
u4ul98i o6jjp
29 Nov 18
Draft registration statement (amended)
12:00am
DRS
jw51sr4yh5
11 Oct 18
Draft registration statement
12:00am
- Prev
- 1
- Next